Prelude Therapeutics Inc · Brief

Next report

11 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26±17.9%▲+10.14%×0.57

quarterimplied−20%0+20%realized×

Q2 FY26±17.9%▲+10.14%×0.57

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 11 report · est.

Bull2

77managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+30.85%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

3 of 20of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

7managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

PRLD report session

No linked exposure.

Oct 28impliedImplied move: ±28.7% into Nov 11 earnings (Oct 28 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.